PRODUCT LITERATURE

Pharmacokinetic Profile of Cisapride 20 mg After Once- and Twice-Daily Dosing

---

Cisapride is a substituted piperidinyl benzamide. It is chemically related to metoclopramide but lacks the antidopaminergic
properties of metoclopramide that affect the central nervous system and cause extrapyramidal side effects. Cisapride is indicated
for the symptomatic treatment of patients with nocturnal heartburn due to gastroesophageal reflux disease. Based on extensive assessment of the drug’s pharmacokinetic profile, the currently approved initial oral dosing regimen for cisapride is 10 mg QID.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Acpulsif
Cisapride

Specific Detail Info

CLINICAL THERAPEUTICS’VVOL. 20, NO. 2, 1998

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment